Figure 2.

Mass spectra resulting from MALDI-TOF-MS after immunoprecipitation of TTR in plasma (A) and ascites (B) obtained from women with ovarian cancer. The untreated TTR (I) and the TTR after treatment with dithioretiol (II) are shown.

Gericke et al. BMC Cancer 2005 5:133   doi:10.1186/1471-2407-5-133
Download authors' original image